Article

How much does genetics add to screening? Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.

2022-10-25

Abstract excerpt

<title>Abstract</title> <p>Background The topic of whether genetic screening for cancer risk should be implemented is complex. Using UK Biobank data, we 1) computed optimal risk thresholds for the detection of breast cancer, 2) examined the overlap of high-risk individuals identified by different risk predictors, and 3) evaluated the performance of risk predictor combinations. Patients and methods We studied 24...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7120ec95-0f08-5764-8dcf-259e7886ede7
DOI: 10.21203/rs.3.rs-2188729/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

How much does genetics add to screening? Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.DOI 10.21203/rs.3.rs-2188729/v1Read

Breast cancer risk stratification using genetic and non-genetic risk assessment tools for 246,142 women in the UK Biobank.Semantic proximity Read

Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.Semantic proximity Read

Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestriesSemantic proximity Read

Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.Semantic proximity Read

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.Semantic proximity Read

Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six CountriesSemantic proximity Read

BRCA and beyond: a genome-first approach to familial breast cancer risk assessment.Semantic proximity Read

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C, RAD51D, BARD1</i>, updates to tumour pathology and cancer incidencesSemantic proximity Read

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.Semantic proximity Read

Breast Cancer Risk – From Genetics to Molecular Understanding of PathogenesisSemantic proximity Read

Breast cancer multigene germline panel testing in mainstream oncology based on clinical-public health utility (cancer mortality benefit): ESMO Precision Oncology Working Group recommendationsSemantic proximity Read

Performance of different polygenic risk scores for breast cancer risk prediction: in-depth evaluations across large UK and Australian cohorts.Semantic proximity Read